Chris Olig - Anteris Technologies Bus Director
| AMEUF Stock | USD 6.50 0.43 7.08% |
Insider
Chris Olig is Bus Director of Anteris Technologies
| Phone | 61 13 0055 0310 |
| Web | https://www.anteristech.com |
Anteris Technologies Management Efficiency
The company has return on total asset (ROA) of (0.8433) % which means that it has lost $0.8433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5517) %, meaning that it generated substantial loss on money invested by shareholders. Anteris Technologies' management efficiency ratios could be used to measure how well Anteris Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Richard Areglado | Brainsway | 60 | |
| Anne Werdan | Cutera Inc | N/A | |
| Christopher Yamamoto | Bioventus | N/A | |
| Jeff Welch | Bioventus | N/A | |
| Miguel BeltranDelgado | Bioventus | N/A | |
| Eyal Shamir | Icecure Medical | 63 | |
| Rajiv Silva | Venus Concept | 57 | |
| William MBA | STRATA Skin Sciences | 58 | |
| Burc Sahinoglu | Owlet Inc | N/A | |
| Keith Simeone | STRATA Skin Sciences | N/A | |
| Kenneth CPA | Bluejay Diagnostics | 44 | |
| Aron Tendler | Brainsway | N/A | |
| John Wilson | Rapid Micro Biosystems | 56 | |
| Christopher Jako | Brainsway | 55 | |
| Pr Zangen | Brainsway | 54 | |
| Jason Cook | Bluejay Diagnostics | 42 | |
| Soren Sinay | Venus Concept | 53 | |
| Nikolai Kabelev | STRATA Skin Sciences | 48 | |
| Charles Thier | Cutera Inc | 61 | |
| Naum Muchnik | Icecure Medical | 48 | |
| Rohan Seth | Cutera Inc | 46 | |
Management Performance
| Return On Equity | -2.55 | |||
| Return On Asset | -0.84 |
Anteris Technologies Leadership Team
Elected by the shareholders, the Anteris Technologies' board of directors comprises two types of representatives: Anteris Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anteris. The board's role is to monitor Anteris Technologies' management team and ensure that shareholders' interests are well served. Anteris Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anteris Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| AC FAA, Exec | ||
| Wayne Paterson, Non-Executive Independent Director | ||
| Matthew McDonnell, Chief Officer | ||
| David Denis, Chief Officer | ||
| Stephen Denaro, Independent Sec | ||
| Chris Olig, Bus Director | ||
| Danny Zanardo, Commercial International | ||
| MPH MD, Chief Board |
Anteris Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Anteris Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.55 | |||
| Return On Asset | -0.84 | |||
| Operating Margin | (5.05) % | |||
| Current Valuation | 196.49 M | |||
| Shares Outstanding | 13.9 M | |||
| Shares Owned By Insiders | 13.27 % | |||
| Shares Owned By Institutions | 28.34 % | |||
| Price To Earning | (3.20) X | |||
| Price To Book | 10.09 X | |||
| Price To Sales | 30.51 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Anteris Pink Sheet
Anteris Technologies financial ratios help investors to determine whether Anteris Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Anteris with respect to the benefits of owning Anteris Technologies security.